Kenya is set to benefit from the United Kingdom’s genomic sequencing support as the country intensifies the fight against Covid-19.
Through the UK’s New Variant Assessment Platform Programme, the Kenya Medical Research Institute (Kemri) will have access to the UK unique sequencing and variant assessment capabilities.
In a statement announcing the partnership on Thursday, British High Commissioner, Jane Marriott said the pandemic has only strengthened the relationship between Kenya and the UK.
“Now we will share our expertise to work together in identifying, tracking and responding to new variants with Kenya, saving lives here and around the world,” she said.
“I welcome this partnership with Kenya, to identify, track and respond to new Covid-19 variants and future health threats. No one is safe until we are all safe,” Secretary Raab added.
The genomic sequencing support includes; reagents and equipment to increase in-country sequencing, technical advice, bioinformatics support and training.
Genomic sequencing analyses the virus sample is taken from a diagnosed patient and compares it with other cases. This also helps in identifying available variants of the virus.